公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
2021 | Daratumumab monotherapy for patients with relapsed or refractory natural killer/T-cell lymphoma, nasal type: an open-label, single-arm, multicenter, phase 2 study | Huang, Huiqiang; Zhu, Jun; MING YAO ; Kim, Tae Min; Yoon, Dok Hyun; Cho, Seok-Goo; Eom, Hyeon Seok; Lim, Soon Thye; Yeh, Su-Peng; Song, Yuqin; Kwong, Yok Lam; Kim, Jin Seok; Jin, Jie; Shi, Yuankai; Kim, HyeJin; Qing, Min; Zhou, Tianyuan; Gao, Grace; Dong, Zongqi; Qi, Ming; Kim, Won Seog | Journal of hematology & oncology | 37 | 37 | |
1995 | Detection of dural involvement by magnetic resonance imaging in adult patients with acute leukemias - preliminary experience | Wu C.-Y.; JIH-LUH TANG ; YAO-CHANG CHEN ; HWEI-FANG TIEN ; Lin M.-T.; MING YAO ; HON-MAN LIU | Annals of Hematology | 7 | 5 | |
2011 | Development of immunity against hepatitis B virus after donor lymphocyte infusion in a peripheral blood stem cell transplantation recipient with chronic hepatitis B | Chiang L.-T.; MING YAO ; BOR-SHENG KO ; CHIEN-HUNG CHEN | Infection | 4 | 5 | |
2018 | Dextran-coated iron oxide nanoparticle-improved therapeutic effects of human mesenchymal stem cells in a mouse model of Parkinson's disease | Chung T.-H.; SZU-CHUN HSU ; Wu S.-H.; Hsiao J.-K.; CHIH-PENG LIN ; MING YAO ; Huang D.-M. | Nanoscale | 52 | 49 | |
2016 | Dextran-coated iron oxide nanoparticles turn protumor mesenchymal stem cells (MSCs) into antitumor MSCs | Chung T.-H.; Hsieh C.-C.; Hsiao J.-K.; SZU-CHUN HSU ; MING YAO ; Huang D.-M. | RSC Advances | 12 | 12 | |
2006 | Diffuse depigmentation in a patient with chronic myeloid leukemia [9] | CHIH-CHIEH CHAN ; MING YAO ; TSEN-FANG TSAI | Journal of the American Academy of Dermatology | 4 | 1 | |
2011 | Distinct association between aberrant methylation of Wnt inhibitors and genetic alterations in acute myeloid leukaemia | HSIN-AN HOU ; Kuo Y.-Y.; Liu C.-Y.; Lee M.C.; JIH-LUH TANG ; Chen, Chien-Yuan ; WEN-CHIEN CHOU ; Huang C.-F.; Lee F.-Y.; Liu M.-C.; MING YAO ; HWEI-FANG TIEN | British Journal of Cancer | 31 | 28 | |
2010 | Distinct clinical and biologic characteristics in adult acute myeloid leukemia bearing the isocitrate dehydrogenase 1 mutation | WEN-CHIEN CHOU ; HSIN-AN HOU ; Chen, Chien-Yuan ; JIH-LUH TANG ; MING YAO ; WOEI TSAY ; BOR-SHENG KO ; SHANG-JU WU ; SHANG-YI HUANG ; SZU-CHUN HSU ; YAO-CHANG CHEN ; Huang Y.-N.; Chang Y.-.; Lee F.-Y.; Liu M.-C.; Liu C.-W.; Tseng M.-H.; Huang C.-F.; HWEI-FANG TIEN | Blood | 179 | 173 | |
2010 | Distinct clinical and biological features of de novo acute myeloid leukemia with additional sex comb-like 1 (ASXL1) mutations | WEN-CHIEN CHOU ; HUAI-HSUAN HUANG ; HSIN-AN HOU ; Chen, Chien-Yuan ; JIH-LUH TANG ; MING YAO ; WOEI TSAY ; BOR-SHENG KO ; SHANG-JU WU ; SHANG-YI HUANG ; SZU-CHUN HSU ; YAO-CHANG CHEN ; Huang Y.-N.; Chang Y.-C.; Lee F.-Y.; Liu M.-C.; Liu C.-W.; Tseng M.-H.; Huang C.-F.; HWEI-FANG TIEN | Blood | 176 | 160 | |
2022 | Distinct clinico-biological features in AML patients with low allelic ratio FLT3-ITD: role of allogeneic stem cell transplantation in first remission | FENG-MING TIEN ; CHENG-HONG TSAI ; Huang, Sheng-Chuan; JIA-HAU LIU ; Chen, Chien-Yuan ; YUAN-YEH KUO ; Chuang, Yi-Kuang; Tseng, Mei-Hsuan; Peng, Yen-Ling; Liu, Ming-Chih; CHIA-WEN LIU ; Liao, Xiu-Wen; LIANG-IN LIN ; Wu, Yu-Sin; Hou, Mei-Fang; SHANG-JU WU ; SZU-CHUN HSU ; BOR-SHENG KO ; WEN-CHIEN CHOU ; MING YAO ; HSIN-AN HOU ; JIH-LUH TANG ; HWEI-FANG TIEN | Bone marrow transplantation | 5 | 6 | |
2022 | Distinct Immunogenetic Profiles of Chronic Lymphocytic Leukemia in Asia: A Taiwan Cooperative Oncology Group Registry Study | CHI-YUAN YAO ; Agathangelidis, Andreas; Chuang, Shih-Sung; Tsou, Hsiao-Hui; Feng, Wei-Lien; Liu, Ta-Chih; Chen, Tsai-Yun; Yu, Yuan-Bin; Yeh, Su-Peng; MING YAO ; Wang, Chuan-Cheng; Lin, Johnson; Hwang, Wen-Li; Gau, Jyh-Pyng; WEN-CHIEN CHOU ; Chao, Tsu-Yi; LIANG-IN LIN ; HWEI-FANG TIEN ; Ghia, Paolo; SHANG-JU WU | HemaSphere | 2 | 1 | |
2016 | Distinct mutation profile and prognostic relevance in patients with hypoplastic myelodysplastic syndromes (h-MDS) | CHI-YUAN YAO ; HSIN-AN HOU ; Lin, Tzung-Yi; CHIEN-CHIN LIN ; WEN-CHIEN CHOU ; Tseng, Mei-Hsuan; Chiang, Ying-Chieh; Liu, Ming-Chih; Liu, Chia-Wen; Kuo, Yuan-Yeh; SHANG-JU WU ; Liao, Xiu-Wen; Lin, Chien-Ting; BOR-SHENG KO ; Chen, Chien-Yuan ; SZU-CHUN HSU ; Li, Chi-Cheng; SHANG-YI HUANG ; MING YAO ; JIH-LUH TANG ; WOEI TSAY ; Liu, Chieh-Yu; HWEI-FANG TIEN | Oncotarget | 19 | 18 | |
2012 | DNMT3A mutations in acute myeloid leukemia: Stability during disease evolution and clinical implications | HSIN-AN HOU ; Kuo Y.-Y.; Liu C.-Y.; WEN-CHIEN CHOU ; Lee M.C.; Chen, Chien-Yuan ; LIANG-IN LIN ; Tseng M.-H.; Huang C.-F.; Chiang Y.-C.; Lee F.-Y.; Liu M.-C.; Liu C.-W.; JIH-LUH TANG ; MING YAO ; SHANG-YI HUANG ; BOR-SHENG KO ; SZU-CHUN HSU ; SHANG-JU WU ; WOEI TSAY ; YAO-CHANG CHEN ; HWEI-FANG TIEN | Blood | 195 | 184 | |
2018 | Dynamics of DNMT3A mutation and prognostic relevance in patients with primary myelodysplastic syndrome | MING-EN LIN ; HSIN-AN HOU ; CHENG-HONG TSAI ; SHANG-JU WU ; Kuo Y.-Y.; Tseng M.-H.; Liu M.-C.; Liu C.-W.; WEN-CHIEN CHOU ; Chen, Chien-Yuan ; JIH-LUH TANG ; MING YAO ; Li C.-C.; SHANG-YI HUANG ; BOR-SHENG KO ; SZU-CHUN HSU ; Lin C.-T.; HWEI-FANG TIEN | Clinical Epigenetics | 30 | 25 | |
2024 | Dysregulated immune and metabolic pathways are associated with poor survival in adult acute myeloid leukemia with CEBPA bZIP in-frame mutations | FENG-MING TIEN ; CHI-YUAN YAO ; Tsai, Xavier Cheng-Hong; Lo, Min-Yen; Chen, Chien-Yuan; WAN-HSUAN LEE ; CHIEN-CHIN LIN ; Kuo, Yuan-Yeh; Peng, Yen-Ling; Tseng, Mei-Hsuan; Wu, Yu-Sin; Liu, Ming-Chih; LIANG-IN LIN ; MING-KAI CHUANG ; BOR-SHENG KO ; MING YAO ; Tang, Jih-Luh; WEN-CHIEN CHOU ; HSIN-AN HOU ; HWEI-FANG TIEN | Blood cancer journal | 0 | | |
2007 | The effect of surface charge on the uptake and biological function of mesoporous silica nanoparticles in 3T3-L1 cells and human mesenchymal stem cells | Chung T.-H.; Wu S.-H.; MING YAO ; Lu C.-W.; Lin Y.-S.; Hung Y.; CHUNG-YUAN MOU ; YAO-CHANG CHEN ; Huang D.-M. | Biomaterials | 557 | 514 | |
2007 | Epidemiology of multiple myeloma in Taiwan: Increasing incidence for the past 25 years and higher prevalence of extramedullary myeloma in patients younger than 55 years | SHANG-YI HUANG ; MING YAO ; JIH-LUH TANG ; WEN-CHUNG LEE ; WOEI TSAY ; ANN-LII CHENG ; Wang C.-H.; YAO-CHANG CHEN ; MING-CHING SHEN ; HWEI-FANG TIEN | Cancer | 84 | 71 | |
1995 | Erratum: Detection of dural involvement by magnetic resonance imaging in adult patients with acute leukemias - Preliminary experience (Annals of Hematology (1995) 70 (243-249)) | Wu C.-Y.; JIH-LUH TANG ; YAO-CHANG CHEN ; HWEI-FANG TIEN ; Lin M.-T.; MING YAO ; HON-MAN LIU | Annals of Hematology | 0 | 0 | |
2008 | Expression of angiopoietins and vascular endothelial growth factors and their clinical significance in acute myeloid leukemia | HSIN-AN HOU ; WEN-CHIEN CHOU ; LIANG-IN LIN ; JIH-LUH TANG ; Tseng M.-H.; Huang C.-F.; MING YAO ; Chen, Chien-Yuan ; WOEI TSAY ; HWEI-FANG TIEN | Leukemia Research | 57 | 50 | |
2014 | Expression of cereblon protein assessed by immunohistochemicalstaining in myeloma cells is associated with superior response of thalidomide- and lenalidomide-based treatment, but not bortezomib-based treatment, in patients with multiple myeloma | SHANG-YI HUANG ; CHUNG-WU LIN ; Lin H.-H.; MING YAO ; JIH-LUH TANG ; SHANG-JU WU ; YAO-CHANG CHEN ; Lu H.-Y.; HSIN-AN HOU ; Chen, Chien-Yuan ; WEN-CHIEN CHOU ; WOEI TSAY ; Chou S.-J.; HWEI-FANG TIEN | Annals of Hematology | 53 | 48 | |